Telomere length shows no association with BRCA1 and BRCA2 mutation status.
This study aimed to determine whether telomere length (TL) is a marker of cancer risk or genetic status amongst two cohorts of BRCA1 and BRCA2 mutation carriers and controls. The first group was a prospective set of 665 male BRCA1/2 mutation carriers and controls (mean age 53 years), all healthy at...
Saved in:
| Main Authors: | Emma Killick, Malgorzata Tymrakiewicz, Clara Cieza-Borrella, Paula Smith, Deborah J Thompson, Karen A Pooley, Doug F Easton, Elizabeth Bancroft, Elizabeth Page, Daniel Leongamornlert, IMPACT collaborators, Zsofia Kote-Jarai, Rosalind A Eeles |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0086659 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prostate Cancer: genetics in practice now and in the future
by: Jana McHugh, et al.
Published: (2025-03-01) -
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
by: Tuya Pal, et al.
Published: (2024-11-01) -
Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients
by: A. A. Kashintsev, et al.
Published: (2016-02-01) -
LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER
by: M. M. Tsyganov, et al.
Published: (2020-07-01) -
BRCA1, BRCA2 mutations — future of predictive oncology: a review of literature
by: V. N. Dmitriev, et al.
Published: (2014-07-01)